Bafna Pharmaceuticals Limited — Board Meeting, 06-02-2025: Outcome of Board Meeting

The Board of Directors of Bafna Pharmaceuticals has convened a meeting and approved the unaudited financial results for the quarter and nine months ended December 31, 2024. The company reported revenue from operations at ₹33.18 Cr and total income of ₹33.38 Cr for the quarter. The total expenses amounted to ₹32.42 Cr, resulting in a profit before tax of ₹0.95 Cr. The board also discussed strategies moving forward and the company’s ongoing compliance efforts related to public shareholding standards.